Description
ASTAL LABORATORIES LIMITED lists 939,930 equity shares issued on preferential basis pursuant to conversion of warrants, with trading commencing October 8, 2025.
Summary
BSE announces the listing of 939,930 equity shares of ASTAL LABORATORIES LIMITED (Scrip Code: 512600) with effect from Wednesday, October 8, 2025. These shares were issued to non-promoters on a preferential basis pursuant to conversion of warrants at an issue price of Rs. 40.00 per share (face value Rs. 10.00 with premium of Rs. 30.00). All shares are subject to lock-in until April 30, 2026.
Key Points
- 939,930 new equity shares of Rs. 10.00 each issued at Rs. 40.00 per share
- Issued to non-promoters on preferential basis pursuant to warrant conversion
- Distinctive numbers: 9856371 to 10796300
- Shares rank pari-passu with existing equity shares
- ISIN: INE307N01014
- Date of allotment: August 12, 2025
- All shares under lock-in until April 30, 2026
Regulatory Changes
No regulatory changes announced in this circular.
Compliance Requirements
- Trading members are informed to note the listing of new securities
- Lock-in restrictions must be observed for all 939,930 shares until April 30, 2026
Important Dates
- Allotment Date: August 12, 2025
- Trading Commencement: October 8, 2025
- Lock-in Expiry: April 30, 2026
Impact Assessment
This is a routine listing announcement with minimal market impact. The preferential allotment represents warrant conversion, adding approximately 940,000 shares to the trading float. However, all shares are locked-in for approximately 6.5 months (until April 30, 2026), preventing immediate trading or sale by allottees. The dilution impact depends on existing share capital but the lock-in period provides stability. Trading members should note the lock-in restrictions when processing client orders.
Impact Justification
Routine listing of shares from warrant conversion with limited market impact due to relatively small size and lock-in restrictions until April 2026